Episode 257: 256. EMPEROR-Reduced- Cardiovascular Outcomes with Empagliflozin in Heart Failure
Questioning Medicine14 Mars 2024

Episode 257: 256. EMPEROR-Reduced- Cardiovascular Outcomes with Empagliflozin in Heart Failure


NNT of 20 to prevent 1 hospitalization at 16 months of follow up

They composite outcome was driven by decrease hospitalizations NOT death

https://www.nejm.org/doi/full/10.1056/NEJMoa2022190


Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
rss-jossan-nina
inga-beiga-morsor
alska-oss
rss-vuxna-pa-latsas
sexnoveller-deluxe
angestpodden
johannes-hansen-podcast
not-fanny-anymore
rss-viktmedicinpodden
sova-med-dan-horning
brottarbroder
sa-in-i-sjalen
rss-the-house-podcast-3
rss-basta-livet
rss-sjalsligt-avkladd
rss-psykoterapipodden
smartare-fitness-podden
dodsdomar